BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9921982)

  • 1. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.
    Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M
    Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
    Hedley DW; Rugg CA; Gelber RD
    Cancer Res; 1987 Sep; 47(17):4729-35. PubMed ID: 3621170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.
    Esteban F; de Vega DS; Garcia R; Rodriguez R; Manzanares J; Almeida A; Tamames S
    Hepatogastroenterology; 1999; 46(27):2039-43. PubMed ID: 10430394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations.
    Visscher DW; Zarbo RJ; Jacobsen G; Kambouris A; Talpos G; Sakr W; Crissman JD
    Lab Invest; 1990 Mar; 62(3):370-8. PubMed ID: 1690316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of newly formed blood vessels in the tumors of patients with breast cancer].
    Jakić-Razumović J; Blazicević V; Uzarević B; Petrovecki M
    Lijec Vjesn; 2002 May; 124(5):123-8. PubMed ID: 12152410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
    Nimmrich I; Sieuwerts AM; Meijer-van Gelder ME; Schwope I; Bolt-de Vries J; Harbeck N; Koenig T; Hartmann O; Kluth A; Dietrich D; Magdolen V; Portengen H; Look MP; Klijn JG; Lesche R; Schmitt M; Maier S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2008 Oct; 111(3):429-37. PubMed ID: 17965955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative DNA analysis of breast cancer by flow cytometry and image analysis.
    Borgiani L; Cogorno P; Toso F; Gallo L; Buccaran G; Rovida S; Canepa M
    Pathologica; 1994 Aug; 86(4):356-9. PubMed ID: 7535909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Datta Gupta S; Pandya P; Ralhan R
    Clin Biochem; 2010 Mar; 43(4-5):373-9. PubMed ID: 19879256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications.
    Hu XC; Wong IH; Chow LW
    Oncol Rep; 2003; 10(6):1811-5. PubMed ID: 14534701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aberrant methylation of APC and Bikunin CpG islands in sporadic breast carcinomas].
    Chen YL; Xie YT; Wen XZ; Deng DJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():17-9. PubMed ID: 17767851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.
    Acs G; Dumoff KL; Solin LJ; Pasha T; Xu X; Zhang PJ
    Am J Surg Pathol; 2007 Jan; 31(1):129-40. PubMed ID: 17197929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.